|
ZNF200 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.034390E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.739330E-03 |
| Normal-vs-Stage2 |
1.680780E-01 |
| Normal-vs-Stage3 |
4.297800E-01 |
| Normal-vs-Stage4 |
2.694000E-01 |
| Stage1-vs-Stage2 |
4.388000E-01 |
| Stage1-vs-Stage3 |
6.835900E-03 |
| Stage1-vs-Stage4 |
6.692300E-02 |
| Stage2-vs-Stage3 |
4.061400E-01 |
| Stage2-vs-Stage4 |
6.281200E-01 |
| Stage3-vs-Stage4 |
6.786200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.253560E-02 |
| Normal-vs-AfricanAmerican |
1.491050E-01 |
| Normal-vs-Asian |
5.699800E-02 |
| Caucasian-vs-AfricanAmerican |
7.734800E-01 |
| Caucasian-vs-Asian |
3.816600E-01 |
| AfricanAmerican-vs-Asian |
3.342400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.222100E-02 |
| Normal-vs-Female |
8.799400E-03 |
| Male-vs-Female |
2.683000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.213160E-01 |
| Normal-vs-Age(41-60Yrs) |
7.337700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.139800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.792800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.383800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.439400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.888570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.403600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.506500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.380190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.416200E-03 |
| Normal-vs-Grade 2 |
3.178700E-04 |
| Normal-vs-Grade 3 |
2.047800E-01 |
| Normal-vs-Grade 4 |
7.712400E-01 |
| Grade 1-vs-Grade 2 |
4.135200E-01 |
| Grade 1-vs-Grade 3 |
2.876500E-02 |
| Grade 1-vs-Grade 4 |
5.198400E-02 |
| Grade 2-vs-Grade 3 |
1.836770E-03 |
| Grade 2-vs-Grade 4 |
6.384200E-03 |
| Grade 3-vs-Grade 4 |
4.800200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.229600E-04 |
| Normal-vs-ccB subtype |
1.342420E-01 |
| ccA subtype-vs-ccB subtype |
1.053670E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.508300E-02 |
| Normal-vs-N1 |
4.984600E-01 |
| N0-vs-N1 |
9.262600E-01 |
|
|
